SOD2 and non-small cell lung carcinoma: Additionally, ceramide treatment has been found to trigger an increase in ROS, modulate the SOD1/SOD2 ratio, and hinder the proliferation of NSCLC cells, thereby suggesting potential therapeutic avenues [34, 35].